Job cuts limit cardiovascular and diabetes research and development
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
List view / Grid view
News
Manufacturing of paediatric medicines set to improve with new investments
A pharmaceutical company and a local council have announced investments to improve paediatric medicines manufacturing.
US$150 million invested to expand US pharmaceutical distribution network
DHL Supply Chain is investing millions of dollars to expand its pharmaceutical and medical device distribution network in the US.
Premier Pharmacy Labs recalls products after FDA inspection
The company has announced a recall of products which were intended to be sterile after a lack of sterility assurance.
FDA announces new data points to aid generic drug developers
The FDA has released new data points which increase transparency for generic-drug competitors.
Lynparza has been approved for BRCA-mutated advanced ovarian cancer
BRCA-mutated advanced ovarian cancer treatment has been approved by the European Commission.
FDA joins blockchain system for drug safety
A multi-company system to improve traceability of pharmaceutical products is newly supported by the FDA.
Four pharmaceutical companies accused of illegal anti-competitive conduct
The CMA has revealed findings that provisionally show that four pharmaceutical companies have broken the law.
Study reveals the risk inactive ingredients pose
Researchers have found that many pharmaceutical products contain inactive ingredients which can be dangerous to patients.
Type 2 diabetes treatment approved for children and adolescents
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
Biopharmaceutical contract manufacturing market expected to rise 10.6 percent
A study has predicted that the global biopharmaceutical contract manufacturing market will grow by 10.6 percent from 2017 to 2027.
MHRA issues recall of paracetamol tablets
A drug alert has been issued for two batches of paracetamol tablets found to have discolourations due to fungi.
US-China trade war leaves gap for Indian pharma to grow
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
US Food and Drug Administration sued over Ruzurgi drug approval
Catalyst Pharmaceuticals Inc has sued the FDA to challenge the recent approval of a lower-cost rival drug.
Pharmaceutical packaging/labelling market to increase 5.3 percent
A new report predicts that the packaging and labelling industry for pharmaceutical products will increase by 5.3 percent.
